Altamira Therapeutics (CYTOF) Live Share Price, Invest From India

Altamira Therapeutics Stock Performance

as on October 21, 2026 at 1:53 am IST

Day's Low
Day's High
$0.08
Day's Price Range
$0.08
$0.08
5.66%
Downside
-5.66%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.08
100.00%
Downside
-100.00%
Upside

Altamira Therapeutics share price movements today

Previous Close: $0.09
Open: $0.08
Volume: 1.6K
Market Cap: $485.8K
Day's Low - High: $0.08 - $0.08

Altamira Therapeutics Historical Returns

1 Month Return: + 18.49 %
3 Month Return: + 69.34 %
1 Year Return: -15.16 %
3 Year Return: 0 %
5 Year Return: 0 %

Altamira Therapeutics Stock Fundamentals & Key Indicators

Check Altamira Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$485.8K

EPS (TTM)

-228.63

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

Return On Equity TTM

-108.79%

Altamira Therapeutics stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Altamira Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Altamira Therapeutics	NA	$485.8K	NA	NA	0.00%	0.00%

Stock Returns calculator for Altamira Therapeutics Stock including INR - Dollar returns

The Altamira Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Altamira Therapeutics investment value today

Current value as on today

₹91,718

Returns

-₹8,282

(-8.28%)

Returns from Altamira Therapeutics Stock

-₹15,200 (-15.2%)

Dollar Impact

₹6,918 (+6.92%)

Altamira Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023
Total Revenue	-	-	-	-	0	0	0	-	0	0
Gross Profit	-	-	-	-	0	0	0	-	0	0
Operating Income	-3	-3	-4	5	-4	-4	-3	5	-2	-2
EBITDA	-3	-3	-4	5	-4	-4	-3	5	0	0
Interest Expense	-	-	-	-	-	-	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	2	2
Income Before Tax	-3	-3	-5	5	-4	-4	-9	0	-2	-2
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-3	-3	-5	5	-4	-4	-9	0	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-309.99%	-309.99%	127.43%	0.00%	-101.18%	-101.18%

Altamira Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Total Revenue	1	0	0	0	0	-
Gross Profit	1	0	0	-2	-1	-
Operating Income	-10	-7	-5	-17	-26	-5
EBITDA	-10	-7	-5	-6	-17	-1
Interest Expense	1	0	0	0	0	-
Depreciation	0	0	0	0	0	5
Income Before Tax	-11	-6	-8	-17	-26	-7
Income Tax Expense	0	0	0	0	0	-
Net Income	-11	-6	-8	-17	-26	-7
Net Profit Margin	100.00%	100.00%	100.00%	-3407.33%	-372.44%	0.00%

Altamira Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023
Net Income	-3	-3	-5	-5	-4	-4	-9	-8	-2	-2
Operating Cash Flow	-2	-2	-4	-4	-2	-2	-1	-1	-3	-3
Investing Cash Flow	0	0	0	0	0	0	0	0	0	0
Financing Cash Flow	1	1	1	1	3	3	1	1	3	3
Change in Cash	-1	-1	-3	-4	0	0	0	0	0	-

Altamira Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Net Income	-11	-6	-8	-17	-26	-3
Operating Cash Flow	-13	-8	-4	-13	-8	-11
Investing Cash Flow	-1	-3	-2	-3	-2	1
Financing Cash Flow	5	7	16	6	9	10
Change in Cash	-9	-4	9	-10	0	0

About Altamira Therapeutics

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders. The firm focuses on the development of intranasal betahistine for the treatment of vertigo and for the prevention of antipsychotic-induced weight gain and somnolence. It also includes other programs under development such as Keyzilen, for the treatment of acute inner ear tinnitus; and Sonsuvi, for the treatment of acute inner ear hearing loss. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

Organisation	Altamira Therapeutics
Headquarters	Clarendon House,2 Church Street, , Hamilton, , US
Industry	Biotechnology
CEO	Thomas Meyer

Key Management of Altamira Therapeutics

Name	Title
Dr. Thomas Meyer Ph.D.	Founder, President, Chairman, CEO & MD
Mr. Marcel Gremaud CPA	Chief Financial Officer
Dr. Covadonga Paneda	Chief Operating Officer
Dr. Samuel A. Wickline M.D.	Chief Scientific Adviser

FAQs

What is Altamira Therapeutics share price today?

Altamira Therapeutics share price today is $0.08 as on October 20, 2026 at 8:23 pm IST. Altamira Therapeutics share today touched a day high of $0.08 and a low of $0.08.

What is the 52 week high and 52 week low for Altamira Therapeutics share?

Altamira Therapeutics share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Altamira Therapeutics stock price today i.e. October 20, 2026 at 8:23 pm IST is trending at $0.08,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Altamira Therapeutics's market capitalisation today?

Altamira Therapeutics market capitalisation is $0.00T as on October 20, 2026 at 8:23 pm IST.

How to invest in Altamira Therapeutics Stock (CYTOF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Altamira Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Altamira Therapeutics Stock (CYTOF) from India?

Indian investors can start investing in Altamira Therapeutics (CYTOF) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 1:12 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Altamira Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 1:12 am IST). Based on Altamira Therapeutics share’s latest price of $0.08 as on October 20, 2026 at 8:23 pm IST, you will get 117.9245 shares of Altamira Therapeutics. Learn more about fractional shares .